← All trials
NCT05939167
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 10, 2023
- Primary completion
- Jul 10, 2025
- Completion date
- Jul 10, 2026
- First posted
- Jul 11, 2023
- Last posted
- Dec 11, 2023
- Enrollment
- 120
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- People's Liberation Army of ChinaCollaborator
- People's Liberation Army of ChinaOverall official - principal investigator
- Capital Medical UniversityCollaborator
- Shenzhen Third People's HospitalCollaborator
- People's Liberation Army of ChinaOfficial
- Fifth Hospital of Shijiazhuang CityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.